Close Menu

SBIR grant

The grant project is part of the company's ongoing effort to expand into pre-designed research tests for disease biomarkers and point-of-care diagnostics.

The company is using a $3 million, three-year grant to clinically validate the test, which it hopes will be the first of its kind approved by the FDA.

The company has previously published data showing the miRNA expression in plasma could identify patients with mild cognitive impairment with 96 percent accuracy.

The fully automated self-confirming assay will simultaneously detect HIV/AIDS antibodies and viral RNA in a single specimen.

NEW YORK (GenomeWeb) – Advanced Cell Diagnostics today announced it has been awarded a two-year $1.4 million grant from the National Cancer Institute to develop and validate a diagnostic test for differentiating various B-cell non-Hodgkin lymphomas from benign lymphoproliferative diseases.

NEW YORK (GenomeWeb) – Mediomics has received a $970,000 Small Business Innovation Research grant from the National Cancer Institute to develop a panel of single-chain variable fragments to detect modified proteins, the company said Friday.

NEW YORK (GenomeWeb) — Bay Area startup Diassess has been awarded nearly $300,000 from the National Institutes of Health for the first year of a two-year project to develop a point-of-care, nucleic acid amplification-based diagnostic device for sexually transmitted infections, with an initial foc

This article has been updated to correct the name of Intrinsic's CEO.

NEW YORK (GenomeWeb) – The National Institute of Dental and Craniofacial Research will award $2 million to small businesses developing point-of-care diagnostic tests that detect oral pathogens or use biomarkers to screen for, monitor, and diagnose oral diseases.

NEW YORK (GenomeWeb) – Newomics said today that it has received from the National Institutes of Health two Small Business Innovation Research Phase I grants totaling $908,000.

Pages

Google's Project Nightingale has collected health information on millions of Americans, according to the Wall Street Journal.

An opinion piece at The Hill criticizes the proposed plan to collect DNA samples from migrants at the US border.

Nature News writes that women in chemistry are less likely to have their manuscripts accepted for publication.

In PNAS this week: tRNA fragment signature for chronic lymphocytic leukemia, genomic sites sensitive to ultraviolet radiation in melanocytes, and more.